Cancer Treatment Centers of America Announces Collaboration with NantHealth and Allscripts

The Cancer Treatment Centers of America® (CTCA) has announced it is collaborating with NantHealth and Allscripts in implementing a custom technical solution. When there is a smooth integration of the clinical decision support solution, the Clinical Pathways program informs the cancer treatment process without interfering with the clinical workflow of the physician.

Many oncologists contributed to the creation of the clinical operating system’s interface. The direct interface holds comprehensive data on evolving cancer care. Clinical Pathways combines the latest cancer research, treatment regimens, and complementary therapies into the Allscripts Sunrise EHR. This incorporation allows oncologists to create a list of care protocols at the point of care.

The platform allows access to custom regimens, comparison of treatment options, computer order entry, access to guidelines and related information, supporting clinical data and a real-time functionality.

Clinical Pathways creates accountability and helps to improve quality and efficiency as it reduces variability in care. Patients and their clinical teams discuss treatment options, which provides confidence in the prescribed treatment, appropriate for their diagnosis. It can also expedite insurance provider’s approval as the necessary clinical data supporting the selected treatment technique can be provided.

The integration of the eviti® solution and Allscripts Sunrise EHR for Clinical Pathways lets physicians retrieve information from a Medical Library encompassing over 2,700 of the most appropriate, evidence based cancer treatment regimens covering. Clinical Pathways is open for use with every patient at the five CTCA hospital locations.

About Cancer Treatment Centers of America

The Cancer Treatment Centers of America is a network of five hospitals serving cancer patients within the United States. It was founded Richard J Stephenson in 1988 and has its headquarters in Boca Raton, Florida

CTCA relies on an integrative approach to cancer care, which applies conventional treatment methods and integrative therapies to address their side effects. It has been acknowledged for its high patient satisfaction scores and earned recognition from various healthcare organizations.

To Read More : www.myctca.com

Eric Lefkofsky: Harnessing Big Data To Aid Cancer Research

Doctors draw on their previous experience when deciding which cancer treatment to recommend for patients, however, Eric Lefkofsky wants physicians to also have access to the outcome data from people with a similar DNA and RNA makeup as their patient. Until now, drawing on both therapeutic data and genomic information to determine the most effective therapies requires obtaining a grant and then performing a study.

Lefkofsky founded Lightbank, a VC firm, and then started Tempus, a company that enables doctors to make data-driven treatment decisions in real-time. Tempus, one of Lightbank’s startups, aggregated big data into a database using proprietary algorithms to give doctors a way to personalize their patient’s treatment plans.

Lefkofsky donates generously to cancer research through the Lefkofsky Family Foundation. Institutions benefiting from the Lefkofsky’s largess include the Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Stanford University; the University of Michigan and New York’s Weill Cornell Medicine. By founding Tempus, Lefkofsky is doing more than donating money; he is enabling doctors to tailor treatment for patients based on their genetic make-up. Seeing cancer researchers collect overwhelming amounts of data looking for patterns, Lefkofsky knew that he could help them analyze all of the data. Lefkofsky and his wife also donate to the arts; they have provided Chicago’s Museum of Contemporary Art with a grant to offer free admission for youth.

Chicago’s notable entrepreneur co founded Groupon, and multiple other companies including Uptake Technologies and Echo Global Logistics. He has taken three of his companies public, including Groupon, InnerWorkings and Echo Global Logistics.

Lefkofsky currently serves as Groupon’s chairman and as CEO of Tempus. Involvement in his community is important to Lefkofsky; he serves as a trustee of The Museum of Science and Industry, Lurie Children’s Hospital of Chicago, World Business Chicago and The Art Institute of Chicago to learn more: http://adrinkwith.com/eric-lefkofsky/ click here.

How Eric Lefkofsky’s Colossal Genomic Database Will Benefit Cancer Patients

While Eric Lefkofsky graduated from the University of Michigan with a law degree, his real talent is being an entrepreneur who thrives on risk. In fact, Lefkofsky’s latest venture is a genomics company, even though he has no medical background.As the co-founder and CEO at Tempus, Lefkofsky oversees the compilation of a colossal database that physicians can use to personalize cancer therapies. Actually, Tempus is based on utilizing big data, as were Lefkofsky’s previous ventures, therefore it isn’t so unusual that he would compile gene-sequencing test results. With numerous Ph.D.s working at Tempus, Lefkofsky’s role is to bring the data together and make it simple for physicians to utilize. Tempus does this by partnering with hospitals that contribute data in return for software, which doctors will use to compare their cancer patient’s genetic profile to other profiles already in the database, in order to determine which treatments have been successful in similar cases.

In addition to co-founding Tempus, Lefkofsky also co-founded Lightbank, a venture fund that invests in diverse companies, especially startups employing disruptive technologies. Lefkofsky wrote a book titled Accelerated Disruption: Understanding the True Speed of Innovation, where he explains why businesses utilizing disruptive tactics often succeed where others fail. In his book, Lefkofsky warns potential entrepreneurs not to hesitate, because with technology, a competitor could easily overtake them and get their idea to market first.

A Chicago resident, Lefkofsky is active in his community; he sits on the boards of the Art Institute of Chicago, the Children’s Memorial Hospital and The Museum of Science and Industry. Adjunct Professor Eric Lefkofsky also teaches a course on entrepreneurship at the University of Chicago Booth School of Business. If anyone knows about entrepreneurship, it is Lefkofsky, who co-founded InnerWorkings, Echo Global Logistics, MediaBank and ThePoint.com. In his spare time, Lefkofsky oversees the Lefkofsky Foundation, which supports charitable causes around the world.

 

Eric Lefkofsky and his Role at Tempus

Eric Lefkofsky was born and raised in Southfield, Michigan. His mother is a school teacher and his father is a structural engineer. After graduating high school in 1987, Lefkofsky went on to study at the University of Michigan where he graduated in 1991. He then continued to go to school for Juris Doctor and received that in 1993.While still in college, Eric Lefkofsky started out by selling carpet. He fell in love with business and worked hard to ensure that he could grow any business that he wanted. Over the years, Lefkofsky has had been helping to run many businesses including Groupon, LightBank, and Uptake. He also supports several different charity works. In 2016, he cofounded Tempus and has been running the company as the CEO.

What is Tempus?

Tempus is a company that helps doctors to be able to deliver personalized cancer care. In cancer research, it has become imperative to do research into genetic sequencing to offer a personalized plan that works for the individual. Many cancer treatments offer a single treatment that is not individualized. It is more of a one size fits all type of treatment. At Tempus, the lab aided in robotic technology helps to map out the genes and find out what treatments would work best for the type of cancer and the genetic code that the person has.

Tempus has helped make strides in cancer research and in cancer treatment.Lefkofsky is the CEO of the company and helps to ensure the smooth operation of the company. Tempus has helped many people suffering from cancer and has an all-star team of doctors and scientists who can help create a better success rate for those suffering from cancer. Lefkofsky will continue to help this company grow and help those suffering from this disease.